Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 61.1564 | 65 |
GSM780708 | Untreated after 4 days (C2_1) | 77.3692 | 71 |
GSM780709 | Untreated after 4 days (C3_1) | 57.0897 | 62 |
GSM780719 | Untreated after 4 days (C1_2) | 68.0171 | 68 |
GSM780720 | Untreated after 4 days (C2_2) | 71.3718 | 69 |
GSM780721 | Untreated after 4 days (C3_2) | 70.9598 | 69 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 59.1039 | 64 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 65.5837 | 67 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 69.1351 | 69 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 71.8023 | 70 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 71.5343 | 69 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 63.5548 | 66 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 72.1021 | 70 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 74.3939 | 70 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 70.8098 | 69 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 73.909 | 70 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 61.2972 | 65 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 77.5628 | 71 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 68.3891 | 68 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 75.143 | 71 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 63.4351 | 66 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 63.0859 | 66 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 61.5466 | 65 |